The core binding factor (CBF) α interaction domain and the smooth muscle myosin heavy chain (SMMHC) segment of CBFβ-SMMHC are both required to slow cell proliferation

被引:39
作者
Cao, WS
Adya, N
Britos-Bray, M
Liu, PP
Friedman, AD
机构
[1] Johns Hopkins Oncol Ctr, Div Pediat Oncol, Baltimore, MD 21287 USA
[2] NHGRI, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1074/jbc.273.47.31534
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have expressed several variants of core binding factor beta (CBF beta)-smooth muscle myosin heavy chain (SMMHC) from the metallothionein promoter in Ba/F3 cells. Deletion of amino acids 2-11 from the CBF beta segment, required for interaction with CBF alpha, prevented CBF beta-SMMHC from inhibiting CBF DNA binding and cell cycle progression. Deletion of 283 carboxyl-terminal residues from the SMMHC domain, required for multimerization, also inactivated CBF beta-SMMHC. Nuclear expression of CBF beta(Delta 2-11)-SMMHC was decreased relative to CBF beta-SMMHC. CBF beta(Delta 2-11)-SMMHC linked to a nuclear localization signal still did not slow cell growth. The ability of each CBF beta-SMMHC variant to inhibit CBF DNA binding and cell proliferation correlated with its ability to inhibit transactivation by an AML1-VP16 fusion protein. Thus, CBF beta-SMMHC slows cell cycle progression from G(1) to S phase by inhibiting CBF DNA binding and transactivation.
引用
收藏
页码:31534 / 31540
页数:7
相关论文
共 45 条
  • [1] ADYA N, 1998, IN PRESS MOL CELL BI
  • [2] Negative regulation of granulocytic differentiation in the myeloid precursor cell line 32Dcl3 by ear-2, a mammalian homolog of Drosophila seven-up, and a chimeric leukemogenic gene, AML1/ETO(MTG8)
    Ahn, MY
    Huang, G
    Bae, SC
    Wee, HJ
    Kim, WY
    Ito, Y
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (04) : 1812 - 1817
  • [3] BAE SC, 1993, ONCOGENE, V8, P809
  • [4] Core binding factor cannot synergistically activate the myeloperoxidase proximal enhancer in immature myeloid cells without c-Myb
    BritosBray, M
    Friedman, AD
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (09) : 5127 - 5135
  • [5] BRITOSBRAY M, 1998, IN PRESS BLOOD
  • [6] CBF beta-SMMHC, expressed in M4Eo AML, reduced CBF DNA-binding and inhibited the G1 to S cell cycle transition at the restriction point in myeloid and lymphoid cells
    Cao, WS
    BritosBray, M
    Claxton, DF
    Kelley, CA
    Speck, NA
    Liu, PP
    Friedman, AD
    [J]. ONCOGENE, 1997, 15 (11) : 1315 - 1327
  • [7] Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11
    Castilla, LH
    Wijmenga, C
    Wang, Q
    Stacy, T
    Speck, NA
    Eckhaus, M
    MarinPadilla, M
    Collins, FS
    WynshawBoris, A
    Liu, PP
    [J]. CELL, 1996, 87 (04) : 687 - 696
  • [8] Frank R, 1995, ONCOGENE, V11, P2667
  • [9] Golling G, 1996, MOL CELL BIOL, V16, P932
  • [10] FUSION OF THE TEL GENE ON 12P13 TO THE AML1 GENE ON 21Q22 IN ACUTE LYMPHOBLASTIC-LEUKEMIA
    GOLUB, TR
    BARKER, GF
    BOHLANDER, SK
    HIEBERT, SW
    WARD, DC
    BRAYWARD, P
    MORGAN, E
    RAIMONDI, SC
    ROWLEY, JD
    GILLILAND, DG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (11) : 4917 - 4921